Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU

  • Home
  • Newsroom
  • Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU
Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU - Axcellant

Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU

  1. sty 31, 2023

From 31 January 2023, all initial clinical trial applications in the European Union (EU) must be submitted via the Clinical Trials Information System (CTIS).

Patrycja Buczak-Kula

CTIS is now the single-entry point for sponsors and regulators of clinical trials for the submission and assessment of clinical trial data. This follows a one-year transition, during which sponsors could choose whether to apply for a new clinical trial in the EU/EEA in line with the Clinical Trials Directive or under the new Clinical Trials Regulation (CTR), which entered into application on 31 January 2022.

https://www.ema.europa.eu/en/news/use-clinical-trials-information-system-becomes-mandatory-new-clinical-trial-applications-eu

Read more

EU regulatory reforms aim to unlock medtech innovation

The EU is moving forward with key upgrades to its medical device and diagnostics regulations, specifically under the Medical Device…

Gene therapy expands beyond oncology — and brings new challenges

Gene therapies now account for most ATMP clinical trials, with a balanced distribution between in vivo and ex vivo approaches.…

How US NIH funding cuts may impact global health innovation

Academic medical centers in the US are voicing concern over reduced funding from the National Institutes of Health (NIH). While…